Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Par Drugs IPO and Sudarshan Pharma IPO.
Par Drugs IPO is a SME Fixed Price Issue IPO proposed to list at NSE SME while Sudarshan Pharma IPO is a SME Fixed Price Issue proposed to list at NSE SME.
| Par Drugs IPO | Sudarshan Pharma IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price Issue | Fixed Price Issue |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Pantomath Capital Advisors Pvt Ltd | First Overseas Capital Limited |
| Registrar | Link Intime India Private Ltd | Kfin Technologies Limited |
| Market Maker | ||
| DRHP | DRHP  |
DRHP |
| RHP | RHP |
RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Par Drugs IPO is up to ₹8.53 Cr whereas the issue size of the Sudarshan Pharma IPO is up to ₹24.77 Cr. The final issue price of Par Drugs IPO is ₹51.00 per share and of Sudarshan Pharma IPO is ₹72.00 per share.
| Par Drugs IPO | Sudarshan Pharma IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹51.00 per share | ₹72.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 1600 shares |
| Fresh Issue Size | 16,72,000 shares | |
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 16,72,000 shares | 34,40,000 shares |
| Issue Size Total (Amount) | up to ₹8.53 Cr | up to ₹24.77 Cr |
Par Drugs IPO opens on May 03, 2019, while Sudarshan Pharma IPO opens on Jun 12, 2019. The closing date of Par Drugs IPO and Sudarshan Pharma IPO is May 08, 2019, and Jun 21, 2019, respectively.
| Par Drugs IPO | Sudarshan Pharma IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | May 03, 2019 | Jun 12, 2019 |
| Issue Close | May 08, 2019 | Jun 21, 2019 |
| Basis Of Allotment (Tentative) | May 13, 2019 | Jun 20, 2019 |
| Initiation of Refunds (Tentative) | May 14, 2019 | Jun 21, 2019 |
| Credit of Share (Tentative) | May 15, 2019 | Jun 24, 2019 |
| Listing date (Tentative) | May 16, 2019 | Jun 25, 2019 |
| Anchor Lockin End date 1 | Jun 12, 2019 | Jul 20, 2019 |
| Anchor Lockin End date 2 | Aug 11, 2019 | Sep 18, 2019 |
Par Drugs IPO P/E ratio is , as compared to Sudarshan Pharma IPO P/E ratio of .
| Par Drugs IPO | Sudarshan Pharma IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.55% | 89.29% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 72.82 | 65.63% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Par Drugs IPO retail investors (RII) are offered 7,80,000 shares while in Sudarshan Pharma IPO retail investors are offered 7,80,000 shares. Qualified institutional buyers (QIB) are offered in Par Drugs IPO and in Sudarshan Pharma IPO.
| Par Drugs IPO | Sudarshan Pharma IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 84,000 shares | 1,76,000 shares |
| QIB | ||
| NII | 7,78,000 shares | 16,32,000 shares |
| RII | 7,80,000 shares | 16,32,000 shares |
| Employee | 30,000 shares | |
| Others | ||
| Total | 15,58,000 shares | 32,64,000 shares |
Par Drugs IPO subscribed 5.74x in total, whereas Sudarshan Pharma IPO subscribed 0.47x.
| Par Drugs IPO | Sudarshan Pharma IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 3.48x | 0.17x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 7.97x | 0.77x |
| Employee (times) | 1.00x | |
| Other (times) | ||
| Total (times) | 5.74x | 0.47x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
